Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4335 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Completed
Has Results
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
Condition: Condylomata Acuminata
8 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
9 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
10 Recruiting Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Behavioral: Stick To It
11 Not yet recruiting Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Tenofovir;   Drug: Lamivudine;   Drug: Efavirenz
12 Completed Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care
Conditions: HIV Infection;   Adherence
Intervention: Behavioral: Intervention
13 Not yet recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir (CAB) tablet;   Drug: Rilpivirine (RPV) tablet;   Drug: Cabotegravir - Injectable Suspension (CAB LA);   Drug: Rilpivirine - Injectable Suspension (RPV LA);   Drug: ABC/DTG/3TC STR - Tablet;   Drug: DTG Tablet
14 Not yet recruiting Alcohol Research Consortium in HIV-Intervention Research Arm
Conditions: HIV Positive;   Alcohol Use
Interventions: Behavioral: Computerized Brief Intervention (CBI);   Behavioral: CBT4CBT;   Drug: Recommendation and Counseling for Alcohol Pharmacotherapy
15 Recruiting Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders
Conditions: Impaired Cognition;   HIV Infection
Intervention: Behavioral: MBSR
16 Active, not recruiting Integrated Treatment and Prevention for People Who Inject Drugs
Condition: HIV Positive
Intervention: Behavioral: Integrated Intervention
17 Not yet recruiting Optimization of Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil;   Drug: Lamivudine;   Drug: Efavirenz
18 Completed Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Maraviroc
19 Recruiting A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: ESTEEM;   Behavioral: CMHT;   Behavioral: VCT
20 Active, not recruiting Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
Condition: Human Immunodeficiency Virus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years